Unusual pathogen: Fatal viral infection identified during advanced cancer immunotherapy
Modern immunotherapy may leave patients vulnerable to rare and potentially severe infections, according to a case study by researchers at the University Medical Center Hamburg-Eppendorf (UKE) and the Leibniz Institute of Virology (LIV). The team identified an avian virus, typically harmless to human
<p>Modern immunotherapy may leave patients vulnerable to rare and potentially severe infections, according to a case study by researchers at the University Medical Center Hamburg-Eppendorf (UKE) and the Leibniz Institute of Virology (LIV). The team identified an avian virus, typically harmless to human</p>